Search

You searched for "cosmeceuticals"

79 results found

ACE 2023

10 March 2023 -11 March 2023
ACE 2023 ACE, the leading aesthetics conference and exhibition, is back with two days of unmissable networking and content. Taking place on 10-11 March at the Business Design Centre in London, ACE 2023 is the must-attend event for all medical...

ACE 2024

15 March 2024 -16 March 2024
ACE, the leading aesthetics conference and exhibition, returns for 2024 with two unmissable days of networking and educational content. Taking place on 15–16 March at the Business Design Centre in London, ACE 2024 is the must-attend event for all medical...

Bruxism: a practical guide to treatment with botulinum toxin type A

1 August 2017 | | PMFA - Aesthetic Medicine
The aetiology of bruxism is outlined and referenced, giving a clear context to the reader. Recommended treatment options are listed, with a brief summary of the evidence concerning pharmaceutical options, oral appliances, splints, psychology and physiotherapy. The author discusses a...

Treatment of facial subcutaneous fibrosis with hyaluronic acid

12 October 2021 | | PMFA - CPD
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Systemic sclerosis (SSc) is a rare and chronic connective tissue disease (CTD)...

Hello and goodbye: changes to The PMFA Journal Editorial Board

3 November 2021
The PMFA Journal team are delighted to welcome three new Specialist Advisors to our Editorial Board, each of whom will broaden our expertise and offer new perspectives to the Journal.

How I Do It - Contouring the lower jaw (surgical)

1 October 2014 | | PMFA - Facial Plastic Surgery
It is essential to clearly understand the patient’s needs so I usually see patients three to four times prior to operating if major changes to appearance are planned. You must also be able to manage expectations and postoperative outcomes; for...

A short overview of the evolution of botulinum toxin type A formulations

1 June 2023 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...

IMCAS 2023

1 February 2023 | Awards, Conferences & Anniversaries
Ethics in Aesthetic Medicine: presented the Consensus Paper of the major international experts

What’s new in treating hypertrophic scars and keloids?

1 June 2018 | | PMFA - Dermatology
World renowned dermatologist, Michael H Gold, explains new treatments available in the challenging field of hypertrophic scar and keloid management. The treatment of hypertrophic scars and keloids remains one of the most challenging conditions that dermatologists face on a regular...

FACE 2015

1 August 2015 |
This was undoubtedly the biggest and most prestigious UK conference of the year. The international mix of both delegates and presenters brought together knowledge, skill and allowed us to experience a jam-packed agenda covering all aspects of aesthetic medicine. The...

Gross Negligence Manslaughter in Healthcare: The medico-legal dilemma (part 16) – Aggravating factors

28 February 2022 |
The Judge just cannot say, “Lee’s airway and oxygenation were not established or maintained”. This is nonsensical from the perspective of a person trained in medicine. Even more senseless from a person who is not. If Lee’s airway was not established and maintained, how did Lee survive a three-hour operation, albeit in the prone position and without developing any signs of cyanosis?

The 5 Rs of the renaissance. The new paradigm in aesthetic medicine

22 October 2024
The Renaissance was a period of great importance in human history where art and science came together to define ideal beauty. This same search for harmony is reflected in current aesthetic medicine, where proportion and symmetry are considered fundamental. For...